Decoding Variable Responses to Anti-VEGF Therapy in AMD and DME Care
Charles Turck, PharmD, BCPS, BCCCP
Joseph M. Coney, MD
Risk of RVO in Type 2 Diabetes: GLP-1 Receptor Agonists Versus DPP-4 Inhibitors
Marlene Mimi Maeusli, PhD.
OCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
Myopia Control in Europe: The Case for Upfront Investment in Childhood
Combination Therapy Slows Myopia Progression in Children with Premyopia
Tackling the Myopia Epidemic: Causes, Consequences, and Opportunities for Prevention
Ryan Quigley
Michael D. Twa, OD, PhD, FAAO
David A. Berntsen, OD, PhD, FAAO
Advancing Myopia Detection and Treatment: A Look at Novel Innovations
Retinal Vein Occlusion as a Predictor of Stroke
Anti-VEGF Use in Retinal Vein Occlusion: Insights from a Real-World Cohort
High Myopia and Visual Disability: New Evidence from a Spanish Clinical Cohort
Rethinking Contact Lenses for Myopic Kids: Why Age 7 Isn’t Too Young
Jeffrey Walline, OD, PhD
Debunking Myopia Myths: Kids Are Safer Contact Lens Wearers Than You May Think
Moving Beyond Correction: WCO’s Standard of Care for Myopia Management
Early Axial Length Changes Signal Red Light Therapy Success in Myopia Control
7 Public Health Strategies to Combat Myopia
New Strategies for Individualizing Treatment in DME
Luis A. Gonzalez, MD, MPH
Jeremiah Brown Jr., MD, MS, FASRS
Loading...
We're glad to see you're enjoying Eye Health Academy… but how about a more personalized experience?
Press cancel to remain on Eye Health Academy. Press the link below or the continue button to keep going.